Kolexia
Fayette Jérôme Oncologie médicale
Fayette Jérôme
Oncologie médicale
Centre Léon-Bérard
Lyon, France
318 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Récidive tumorale locale Métastase tumorale Tumeurs du poumon Carcinome pulmonaire non à petites cellules Sarcomes

Collaborateurs

Voir plus
Even Caroline
Even Caroline
Gustave-Roussy, Villejuif, France
Guigay Joel
Guigay Joel
Centre Antoine Lacassagne, Nice, France
Cupissol Didier
Cupissol Didier
Icm Montpellier, Montpellier, France
Le Tourneau Christophe
Le Tourneau Christophe
Clcc Institut Curie, Paris, France

Industries

Voir plus
IQVIA
143 collaboration(s)
Dernière en 2023
B3TSI
96 collaboration(s)
Dernière en 2023
All Global
65 collaboration(s)
Dernière en 2021
Ipsos Mori UK Limited
61 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
iintune-1: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Essai Clinique (Takeda Pharmaceutical)   07 mars 2024
IMMUNONET: A Multicenter, Open-label, Proof of Concept Phase II Aiming to Assess the Clinical and Biological Activity of Anti-netrin-1 (NP137) as Add on Therapy in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Immunotherapies
Essai Clinique (NETRIS Pharma)   06 mars 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
The Lancet. Healthy longevity   05 mars 2024
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Cancer immunology, immunotherapy : CII   02 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors: Phase 1/2 Dose Escalation and Cohort Expansion Study Evaluating MCLA-158 (Petosemtamab) as Single Agent or in Combination in Advanced Solid Tumors
Essai Clinique (Merus N.V.)   01 mars 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
ELAN-UNFIT: Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation
Essai Clinique (Merck-Serono)   07 février 2024
Survival of bronchopulmonary cancers according to radon exposure.
Frontiers in public health   24 janvier 2024
Uncovering immune checkpoint heterogeneity in oral squamous cell carcinoma using single cell RNA-sequencing data highlights three subgroups of patients with distinct immune phenotypes.
Oral oncology   12 janvier 2024